BOSTON — Kerry announced a new partnership with Boston-based biotech company Ginkgo Bioworks. Ginkgo will equip Kerry to use its biotechnology software platform to produce specialty enzymes for the food industry.
 |
| Albert McQuaid, Ph.D., chief technology and innovation officer at Kerry |
“Our company has long been focused on using science and technology to make our processes, ingredients and products better,” said Albert McQuaid, Ph.D., chief technology and innovation officer at Kerry. “Ginkgo Bioworks has a technology platform that we haven’t seen in the enzyme industry before now, and we look forward to leveraging their technology to improve the work we're doing with enzymes in the food industry.”
Ginkgo’s platform uses automated processes and custom software to design and build microbial strains that can produce cultured ingredients and enzymes during the fermentation process. This partnership combines Ginkgo’s technology with Kerry’s ingredient expertise.
 |
| Jason Kelly, co-founder and c.e.o. of Ginkgo Bioworks |
“Our work in food is more than flavors and ingredients; we’re working with companies to put biology to work in strain improvement and enzymes as well,” said Jason Kelly, co-founder and chief executive officer of Ginkgo Bioworks. “Kerry is an industry leader in food development and a market leader in enzymes. The ability to work with Kerry is a huge step forward for Ginkgo’s business. We see this new partnership as a great opportunity to demonstrate the value our technology brings to the food industry.”
